[KROS] QoQ Quarter Result on 30-Sep-2024 [#Q3]

Stock
[KROS] Keros Therapeutics, Inc.
Announcement Date
06-Nov-2024
Financial Year
2024
Quarter
30-Sep-2024 [#Q3]
Profit Trend
QoQ- -17.01%
YoY- -34.27%
Quarter Report
KROS's Result
KROS's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Revenue 388 37 83 143 8 0 0 -
PBT -52,956 -45,257 -43,114 -40,243 -39,440 -37,505 -35,804 29.72%
Tax 0 0 -277 3,812 -210 3,832 -3,065 -
NP -52,956 -45,257 -43,114 -40,243 -39,440 -37,505 -32,739 37.67%
Tax Rate - - - - - - - -
Total Cost 53,344 45,294 43,197 40,386 39,448 37,505 32,739 38.34%
Ratio Analysis
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
NP Margin -13,648.45 -122,316.22 -51,944.58 -28,141.96 -493,000.00 0.00 0.00 -
Per Share
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
EPS -1.47 -1.25 -1.46 -1.34 -1.33 -1.27 -1.15 17.72%
EPS Diluted -1.47 -1.25 -1.46 -1.34 -1.33 -1.27 -1.15 17.72%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.